These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9700634)

  • 41. [Fecal IgA antibody against rotavirus and clinical manifestations of acute viral gastroenteritis in children].
    Fujita Y
    Kansenshogaku Zasshi; 1990 Aug; 64(8):980-5. PubMed ID: 2170543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rotavirus nonstructural protein NSP4 induces heterotypic antibody responses during natural infection in children.
    Ray P; Malik J; Singh RK; Bhatnagar S; Bahl R; Kumar R; Bhan MK
    J Infect Dis; 2003 Jun; 187(11):1786-93. PubMed ID: 12751037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
    Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE
    Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants.
    Yang Y; Li X; Yang H; Qian Y; Zhang Y; Fang R; Chen X
    Sci China Life Sci; 2011 Jan; 54(1):82-9. PubMed ID: 21104033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rotavirus assembly - interaction of surface protein VP7 with middle layer protein VP6.
    Gilber JM; Feng N; Patton JT; Greenberg HB
    Arch Virol; 2001; 146(6):1155-71. PubMed ID: 11504422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
    Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model.
    Feng N; Vo PT; Chung D; Vo TV; Hoshino Y; Greenberg HB
    J Infect Dis; 1997 Feb; 175(2):330-41. PubMed ID: 9203654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The immune response in primary asymptomatic and symptomatic rotavirus infection in newborn infants.
    Losonsky GA; Reymann M
    J Infect Dis; 1990 Feb; 161(2):330-2. PubMed ID: 2153740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection.
    Shaw RD; Groene WS; Mackow ER; Merchant AA; Cheng EH
    J Virol; 1991 Jun; 65(6):3052-9. PubMed ID: 1709695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.
    Azevedo MS; Yuan L; Iosef C; Chang KO; Kim Y; Nguyen TV; Saif LJ
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):12-20. PubMed ID: 14715539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reactivity patterns to human rotavirus strains of a monoclonal antibody against VP2, a component of the inner capsid of rotavirus. Brief report.
    Taniguchi K; Urasawa T; Urasawa S
    Arch Virol; 1986; 87(1-2):135-41. PubMed ID: 3002300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4.
    Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA
    Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rotavirus-neutralizing antibodies inhibit virus binding to integrins alpha 2 beta 1 and alpha 4 beta 1.
    Fleming FE; Graham KL; Taniguchi K; Takada Y; Coulson BS
    Arch Virol; 2007; 152(6):1087-101. PubMed ID: 17318737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracellular neutralisation of rotavirus by VP6-specific IgG.
    Caddy SL; Vaysburd M; Wing M; Foss S; Andersen JT; O'Connell K; Mayes K; Higginson K; Iturriza-Gómara M; Desselberger U; James LC
    PLoS Pathog; 2020 Aug; 16(8):e1008732. PubMed ID: 32750093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
    Afchangi A; Arashkia A; Shahosseini Z; Jalilvand S; Marashi SM; Roohvand F; Mohajel N; Shoja Z
    Viral Immunol; 2018 Apr; 31(3):233-241. PubMed ID: 29185875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recovery and characterization of a replicase complex in rotavirus-infected cells by using a monoclonal antibody against NSP2.
    Aponte C; Poncet D; Cohen J
    J Virol; 1996 Feb; 70(2):985-91. PubMed ID: 8551639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody response in serum and intestine in children up to six months after a naturally acquired rotavirus gastroenteritis.
    Hjelt K; Grauballe PC; Andersen L; Schiøtz PO; Howitz P; Krasilnikoff PA
    J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):74-80. PubMed ID: 3944746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring.
    Coste A; Cohen J; Reinhardt M; Kraehenbuhl JP; Sirard JC
    Vaccine; 2001 Jul; 19(30):4167-74. PubMed ID: 11457542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A.
    O'Neal CM; Harriman GR; Conner ME
    J Virol; 2000 May; 74(9):4102-9. PubMed ID: 10756022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Virus-like particles based on rotavarus A recombinant VP2/VP6 proteins for assessment the antibody immune response by ELISA].
    Filatov IE; Tsibezov VV; Balandina MV; Norkina SN; Latyshev OE; Eliseeva OV; Cherepushkin SA; Verkhovsky OA; Grebennikova TV
    Vopr Virusol; 2023 May; 68(2):161-171. PubMed ID: 37264851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.